U.S. Markets close in 4 hrs 49 mins
  • S&P 500

    +43.28 (+1.21%)
  • Dow 30

    +360.60 (+1.22%)
  • Nasdaq

    +108.28 (+0.91%)
  • Russell 2000

    +30.05 (+1.65%)
  • Crude Oil

    +1.78 (+4.13%)
  • Gold

    -34.40 (-1.87%)
  • Silver

    -0.41 (-1.75%)

    +0.0032 (+0.2732%)
  • 10-Yr Bond

    +0.0200 (+2.33%)
  • Vix

    -0.52 (-2.29%)

    +0.0030 (+0.2283%)

    +0.1630 (+0.1560%)

    +865.68 (+4.69%)
  • CMC Crypto 200

    +13.42 (+3.63%)
  • FTSE 100

    +82.80 (+1.31%)
  • Nikkei 225

    +638.22 (+2.50%)

Sensus Healthcare to Present at the 8th Annual LD Micro Invitational

LOS ANGELES, CA / ACCESSWIRE / May 29, 2018 / Sensus Healthcare, Inc. (SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), today announced that it will be presenting at the 8th Annual LD Micro Invitational on Tuesday, June 5 at 2:30pm PST/5:30pm EST. Joe Sardano, Chairman and Chief Executive Officer of Sensus Healthcare, will be presenting as well as meeting with investors.

Mr. Sardano's presentation will be webcast live on the internet and can be accessed by visiting the Investor Relations section of the Company's website at www.sensushealthcare.com. Following the presentation, a replay of the webcast will be archived on Sensus Healthcare's website for a period of time.

"The event is slated to be our largest Invitational to date," stated Chris Lahiji, President of LD Micro. "When the fires caused the cancellation of our Main Event back in December, we vowed to come back even stronger. This event showcases our firm's ability to attract the most unique and exciting names in micro-cap."

The conference will be held at the Luxe Sunset Bel Air Hotel, will feature 230 companies in the small-cap/micro-cap space, and will be attended by over 1,000 individuals.

View Sensus Healthcare's profile here: www.ldmicro.com/profile/SRTS.

About Sensus Healthcare

Sensus Healthcare, Inc. is a medical device company that is committed to providing non-invasive and cost-effective treatment for non-melanoma skin cancers and keloids. Sensus uses a proprietary low energy X-ray technology known as superficial radiation therapy (SRT), which is a result of over a decade of dedicated research and development. Sensus has successfully incorporated SRT therapy into its portfolio of treatment devices, the SRT-100™ and SRT-100 Vision™. To date, SRT technology has been used to effectively and safely treat oncological and non-oncological skin conditions in thousands of patients. For more information, visit http://www.sensushealthcare.com.

About LD Micro

LD Micro was founded in 2006 with the sole purpose of being an independent resource in the microcap space. The firm hosts several influential conferences annually (Invitational, Summit, and Main Event).

In 2015, LDM launched the first pure microcap index (the LDMi) to exclusively provide intraday information on the entire sector. LD will continue to provide valuable tools for the benefit of everyone in the small and micro-cap universe.

For those interested in attending, please contact David Scher at david@ldmicro.com or visit www.ldmicro.com for more information.

Profiles powered by LD Micro - News Compliments of ACCESSWIRE.


LHA Investor Relations
Kim Sutton Golodetz

SOURCE: Sensus Healthcare